This thread was started by
@antibotter in 2015
directly comparing Starpharma to Telix. His analogy was that Telix (led by Dr Chris Behrenbruch) only had one lollie in the gum ball machine, whereas the rest of the lollies were all Starpharma’s (led by Jackie Fairley). I guess TLX and Dr Behrenbruch have just been very very lucky with there commercialisation success. Or could it be something else?
A few rusted on Starpharma shareholders were calling Dr Behrenbruch a heretic for some of his assessment of Starpharma. However FYI, the well respected Biotech Daily had this to say about Chris Behrenbruch in a 2015 edition….
In June, the sector awoke to a new commentator on the block, Dr Christian Behrenbruch and his ASX Long Tail. Biotech Daily does not comment on commentary, but it is fair to say that Dr Behrenbruch has gingered-up the sector, some of his writing is amusing, some is excruciatingly accurate and some is opinion with which readers may disagree – and to his credit Dr Behrenbruch allows space for disagreement.
